webinar register page

Webinar banner
HIV Prevention Efficacy Trial Designs of the Future
Hosted by The Global HIV Vaccine Enterprise in partnership with the HIV Vaccine Trials Network and the Forum for Collaborative Research.

HIV prevention is evolving rapidly with the roll out of new tools such as pre-exposure prophylaxis (PrEP) and treatment as prevention making a significant contribution towards controlling the epidemic. As a result, the design and conduct of the next generation of prevention trials is impacted and is further affected by the outcomes of ongoing HIV prevention efficacy trials – including oral and injectable antiretrovirals, passively infused monoclonal antibodies, and HIV vaccines.

This series of virtual workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID, which led to a series of articles published in Statistical Communications in Infectious Diseases and a viewpoint in The Lancet HIV.

Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs. They will examine novel scientific approaches for establishing efficacy of new biologics in a future where all trial participants have access to effective prevention.

For more information please visit:
https://vaccineenterprise.org/hiv-prevention-clinical-trial-design-of-the-future/

Feb 25, 2021 05:00 PM in Zurich

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Vaccine Enterprise.